Science Vs cover image

Introducing The Journal: Trillion Dollar Shot

Science Vs

00:00

The Journey of Developing Ozempic: Overcoming Challenges in GLP-1 Research

Explore the early stages of developing a new class of drugs based on GLP-1 hormone to treat diabetes, as recounted by lead researcher Lada Knudsen and her team at Novo Nordisk. Despite facing skepticism, resource limitations, and safety concerns during clinical trials, the team's perseverance and dedication eventually led to the successful development and approval of Ozempic after more than a decade of hard work.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app